BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 12716427)

  • 21. Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines.
    Xiao H; Hirata Y; Isobe K; Kiuchi K
    J Neurochem; 2002 Aug; 82(4):801-8. PubMed ID: 12358785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moracenin D from Mori Cortex radicis protects SH-SY5Y cells against dopamine-induced cell death by regulating nurr1 and α-synuclein expression.
    Ham A; Lee HJ; Hong SS; Lee D; Mar W
    Phytother Res; 2012 Apr; 26(4):620-4. PubMed ID: 21936000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP.
    Vila M; Vukosavic S; Jackson-Lewis V; Neystat M; Jakowec M; Przedborski S
    J Neurochem; 2000 Feb; 74(2):721-9. PubMed ID: 10646524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein.
    Lauwers E; Debyser Z; Van Dorpe J; De Strooper B; Nuttin B; Baekelandt V
    Brain Pathol; 2003 Jul; 13(3):364-72. PubMed ID: 12946025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nurr1 transcriptionally regulates the expression of alpha-synuclein.
    Yang YX; Latchman DS
    Neuroreport; 2008 May; 19(8):867-71. PubMed ID: 18463503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.
    Zhou W; Hurlbert MS; Schaack J; Prasad KN; Freed CR
    Brain Res; 2000 Jun; 866(1-2):33-43. PubMed ID: 10825478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
    Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
    Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease.
    Gründemann J; Schlaudraff F; Haeckel O; Liss B
    Nucleic Acids Res; 2008 Apr; 36(7):e38. PubMed ID: 18332041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.
    Jorge-Finnigan A; Kleppe R; Jung-Kc K; Ying M; Marie M; Rios-Mondragon I; Salvatore MF; Saraste J; Martinez A
    J Biol Chem; 2017 Aug; 292(34):14092-14107. PubMed ID: 28637871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase.
    Elkon H; Don J; Melamed E; Ziv I; Shirvan A; Offen D
    J Mol Neurosci; 2002 Jun; 18(3):229-38. PubMed ID: 12059041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BDNF is induced by wild-type alpha-synuclein but not by the two mutants, A30P or A53T, in glioma cell line.
    Kohno R; Sawada H; Kawamoto Y; Uemura K; Shibasaki H; Shimohama S
    Biochem Biophys Res Commun; 2004 May; 318(1):113-8. PubMed ID: 15110760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The constitutive and inducible expression of Nurr1, a key regulator of dopaminergic neuronal differentiation, in human neural and non-neural cell lines.
    Satoh J; Kuroda Y
    Neuropathology; 2002 Dec; 22(4):219-32. PubMed ID: 12564761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant.
    Wersinger C; Vernier P; Sidhu A
    Biochemistry; 2004 Feb; 43(5):1242-53. PubMed ID: 14756560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis.
    Lee FJ; Liu F; Pristupa ZB; Niznik HB
    FASEB J; 2001 Apr; 15(6):916-26. PubMed ID: 11292651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z; Ferger B; Feldon J; Büeler H
    J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Could a loss of alpha-synuclein function put dopaminergic neurons at risk?
    Perez RG; Hastings TG
    J Neurochem; 2004 Jun; 89(6):1318-24. PubMed ID: 15189334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease.
    Hashimoto M; Takenouchi T; Rockenstein E; Masliah E
    J Neurochem; 2003 Jun; 85(6):1468-79. PubMed ID: 12787066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and assessment of double genes of tyrosine hydroxylase gene and aromatic L-amino acid decarboxylase gene in vitro].
    Su Y; Duan CL; Zhao CL; Zhao HY; Xu QY; Yang H
    Sheng Li Xue Bao; 2003 Oct; 55(5):583-8. PubMed ID: 14566408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.